The online version of this article (doi: 10.1007/s10354-016-0488-4) contains supplementary material, which is available to authorized users.
The analysis of transcriptomics data is able to give an overview of cellular processes, but requires sophisticated bioinformatics tools and methods to identify the changes. Pathway analysis software, like PathVisio, captures the information about biological pathways from databases and brings this together with the experimental data to enable visualization and understanding of the underlying processes. Rett syndrome is a rare disease, but still one of the most abundant causes of intellectual disability in females. Cause of this neurological disorder is mutation of one single gene, the methyl-CpG-binding protein 2 (MECP2) gene. This gene is responsible for many steps in neuronal development and function. Although the genetic mutation and the clinical phenotype are well described, the molecular pathways linking them are not yet fully elucidated. In this study we demonstrate a workflow for the analysis of transcriptomics data to identify biological pathways and processes which are changed in a Mecp2-/y mouse model.
Falk MJ, Shen L, Gonzalez M, Leipzig J, Lott MT, Stassen AP, et al. Mitochondrial Disease Sequence Data Resource (MSeqDR): a global grass-roots consortium to facilitate deposition, curation, annotation, and integrated analysis of genomic data for the mitochondrial disease clinical and research communities. Mol Genet Metab. 2015;114(3):388–96. CrossRefPubMed
Rett A. On a unusual brain atrophy syndrome in hyperammonemia in childhood. Wien Med Wochenschr. 1966;116(37):723–6. PubMed
Johnston M, Blue ME, Naidu S. Recent advances in understanding synaptic abnormalities in Rett syndrome. F1000Res. 2015;4:1490. doi: 10.12688/f1000research.6987.1.
- New insights in Rett syndrome using pathway analysis for transcriptomics data
Susan L. M. Coort
Chris T. Evelo
- Springer Vienna